Sleep, energy and self rated cognition across 7 nights following recreational ecstasy/MDMA use

Sleep and Hypnosis

Volumn 10, Issue 1, 2008, Pages 26-38

  Jones, K A ^a   Callen, F ^a   Blagrove, M T ^a   Parrott, A C ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Cognitive measures; Ecstasy; Energy; MDMA (3, 4 methylenedioxymethamphetamine); Prospective; Sleep

Indexed keywords

EID: 50049134072     PISSN: 13021192     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Green, A. R., Sanchez, V., O'Shea, E., Saadat, K. S., Eliott, J. M., Colado, M. I. (2004). Effect of ambient temperature and a prior neurotoxic dose of 3, 4- methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (binge\ingestion) low dose of MDMA. Psychopharmacology, 173: 264-9.
2. Morgan, M. J. (2000). Ecstasy (MDMA): a review of its possible persistent side effects. Psychopharmacology, 152: 230-48.
3. Rodgers, J., Buchanan, T., Pearson, C., Parrott, A. C., Ling, J., Hefferman, T. M., Scholey, A. B. (2006). Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study. Journal of Psychopharmacology, 20: 437-446
4. Cami, J., Farre, M., Mas, M., Roset, P. N., Poudevida, A. (2000). Human Pharmacology of 3, 4- Methylenedioxymethamphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects. Journal of Clinical Psychopharmacology, 20: 455-466.
5. Liechti, M. E., Baumann, C., Gamma, A., Vollenweider, F. X. (2000). Acute psychological effects of 3, 4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology, 22: 513-521.
6. Montoya, A. G., Sorrentino, R., Lukas, S. E., Price, B. H. (2002). Long- term neuropsychiatric consequences of 'Ecstasy' (MDMA): A review. Harvard Review of Psychiatry, 10: 212-220.
7. McCartle, K., Luebbers, S., Carter, J. D., Croft, R. J., Stough, C. (2004). Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology, 173: 434-439.
8. Soar, K., Parrott, A. C., Turner, J. J. D. (2005). No more the "love drug": sexual behaviour impairments in Ecstasy users. Journal of Psychopharmacology, 19: 25.
9. Soar, K., Turner, J. J. D., Parrott, A. C. (2006). Problematic versus non problematic ecstasy/MDMA use: the influence of drug usage patterns and pre- existing psychiatric factors. Journal of Psychopharmacology, 20: 417-424.
10. Reneman, L., de Win, M. M., van de Brink, W., Booij, den Heeten, G. J. (2006). Neuroimaging findings with MDMA/Ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology, 20: 164-175.
11. Quednow, B. B., Jessen, F., Kuhn, K. U., Maier, W., Daum, I., Wagner, M. (2006). Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. Journal of Psychopharmacology, 20: 373-384
12. Reay, J. L., Hamilton, C., Kennedy, D. O., Scholey, A. B. (2006). MDMA polydrug users show process- specific central executive impairments coupled with impaired social and emotional judgement processes. Journal of Psychopharmacology, 20: 385-388.
13. Parrott, A. C. (2001). Human psychopharmacology of ecstasy: A review of fifteen years of empirical research. Human Psychopharmacology, 16: 557-577.
14. Parrott, A. C. (2006). MDMA in humans: factors that affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. Journal of Psychopharmacology, 20: 147-163
15. Peroutka, S. J., Newman, H., Harris, H. (1988). Subjective effects of 3.4- Methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology, 1: 273-277
16. Solowij, N., Hall, W., Lee, N. (1992) Recreational MDMA use in Sydney: A profile of "Ecstasy" users and their experiences with the drug. British Journal of Addiction, 87: 1161-1172.
17. Cohen, R. S. (1995). Subjective reports on the effects of the MDMA ("ecstasy") experience in humans. Progressive Neuropsychopharmacological Biological Psychiatry, 19: 1137-45
18. Davidson, D., Parrott, A. C. (1997). Ecstasy (MDMA) in recreational users: self reported psychological and physiological effects. Human Psychopharmacology, 12: 221-226.
19. Topp, L., Hando, J., Dillon, P., Roche, A., Solowij, N. (1999). Ecstasy use in Australia: patterns of drug and associated harm. Drug and Alcohol Dependence, 55: 105-115.
20. Verheyden, S. L., Henry, J., Curran, H. V. (2003). Acute, sub-acute and long term subjective consequences of ecstasy (MDMA) consumption in 430 regular users. Human Psychopharmacology, 18: 507-17.
21. Verheyden, S. L., Maidment, R., Curran, H. V. (2003) Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health. Psychopharmacology, 174: 371-378.
22. Colbron, S., Jones, M., Biello, S. M. (2002). MDMA alters the response of the circadian clock to a photic and non- photic stimulus. Brain Research, 956: 45-52.
23. Biello, S. M., Dafters, R. I. (2001). MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro. Brain Research, 920: 202-209.
24. Balogh, B., Molnar, E., Jakus, R., Quate, L., Olverman, H. J., Kelly, P. A. T., Kantor, S., Gyorgy, B. (2004). Effects of a single dose of 3, 4- methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug- naïve rats and rats previously exposed to MDMA. Psychopharmacology, 173: 269-309.
25. Allen RP, McCann UD, Ricuarte GA (1994) Persistent effects of (+-) 3,4-methylene-dioxymethamphetamine (MDMA, "Ecstasy") on human sleep. Sleep 16: 560-564.
26. McCann, U. D., Eligulashvili, V., Ricaurte, G. A. (2000). (+/-) 3, 4- Methylenedioxymethamphetamine ("Ecstasy")- induced serotonin neurotoxicity: clinical studies. Neuropsychobiology, 42: 11-16.
27. McCann, U. D., Peterson, S. C., Ricaurte, G. A. (2007). The effect catecholamine depletion by alpha- methyl- para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology, 38: 1695-1706.
28. McCann, U. D., Ricaurte, G. A. (2007). Effects of (+/-) 3, 4-Methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms. The ScientificWorld Journal, 7: 231-238.
29. Kuypers, K. P. C., Ramaekers, J. G. (2005). Transient memory impairment after acute dose of 75mg 3.4-Methylenedioxymethamphetamine. Psychopharmacology, 19: 633-639.
30. Curran, H. V., Travill, R. A. (1997). Mood and cognitive effects of (+-) 3,4-methylene-dioxymethamphetamine (MDMA "Ecstasy"): weekend 'high' followed by a mid week low. Addiction, 92: 821-831.
31. Parrott, A. C., Lasky, J. (1998). Ecstasy (MDMA) effects upon mood and cognition: before and after a Saturday night dance. Psychopharmacology, 139: 261-8.
32. Curran HV, Rees H, Hoare T, Hoshi R, Bond A. (2004) Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology, 173: 425-433
33. Verheyden, S. L., Hadfield, J., Calin, T., Curran, H. V. (2002). Sub- acute effects of MDMA ((+-) 3,4-methylene-dioxymethamphetamine "Ecstasy") on mood: evidence of gender differences. Psychopharmacology, 161: 23-31.
34. Hoshi, R., Bisla, J., Curran, H. V. (2004). The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings. Drug and Alcohol Dependence, 76: 297-304.
35. Kuypers, K. P. C., Wingen, M., Samyn, N., Limbert, N., Ramaekers, J. G. (2007). Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology, 192: 111-119
36. Hoddes, E., Zarcone, E., Smythe, H., Phillips, R., Dement, W. C. (1973). Quantification of sleepiness: A new approach. Psychophysiology, 10: 431-436.
37. Huxster, J. K., Pirona, A., Morgan, M. J. (2006). The sub-acute effects of recreational ecstasy (MDMA) use: A controlled study in humans. Psychopharmacology, 20: 281-290.
38. Clark- Carter, D. (1997). Doing quantitative psychological research: From design to report. Hove, East Sussex: Taylor & Francis: Psychology Press.
39. Parrott A. C., Buchanan, T., Scholey, A.B., Heffernan, T.M., Ling, J., Rodgers, J. (2002). Ecstasy/MDMA attributed problems reported by novice, moderate and heavy users. Human Psychopharmacology, 17: 309-312.
40. Vollenweider, F. X., Gamma, A., Liechti, M., Huber, T. (1998). Psychological and cardiovascular effects and short- term sequelae of MDMA ("Ecstasy") in MDMA- naïve healthy volunteers. Neuropsychopharmacology, 19: 241-251.
41. Cohen, R. S. (1998). The Love Drug: Marching to the beat of Ecstasy. Haworth Medical Press, New York State.
42. Hoshi, R., Pratt, H., Mehta, S., Bond, A. J., Curran, H. V. (2006). An investigation into the sub- acute effects of ecstasy on aggressive interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology, 181: 550-559.
43. Fisk J. E, Montgomery C, Wareing M, Murphy P. N. (2005). Reasoning deficits in ecstasy (MDMA) polydrug users. Psychopharmacology, 181: 550-559.
44. Parrott, A. C. (2007). Ecstasy versus alcohol: Tolstoy and the variations of unhappiness. Journal of Psychopharmacology, 21: 3-6.
45. Parrott, A., Morinan, A., Moss, M., Scholey, A. (2004). Understanding Drugs and Behaviour. Wiley, Chichester.
46. Parrott, A. C., Rodgers, J., Buchanan, T., Ling, J., Heffernan, T., Scholey, A. B. (2006). Dancing hot on Ecstasy: physical exercise and feeling hot are assosciated with the neuro psychological problems reported by recreational MDMA users. Human Psychopharmacology, 21: 285-298.
47. Rodgers, J., Buchanan, T., Scholey, A. B., Heffernan, T. M., Ling J., Parrott. A. C. (2003). Patterns of drug use and the influence of gender on self reports of memory ability in ecstasy users: a web based study. Journal of Psychopharmacology, 17: 379-386.
48. Harris, D. S., Baggott, M., Mendelson, J. H., Mendelson, J. E., Jones, R. T. (2002). Subjective and hormonal effects of 3, 4-Methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 162: 396-405.
49. Baylen, C. A., Rosenberg, H. (2006). A review of the acute subjective effects of MDMA/ecstasy. Addiction, 101: 933-947.
50. Parrott, A. C., Lock, J., Conner, A. C., Kissling, C., Thome, J. (2008). Dance clubbing on MDMA and during MDMA-abstinence: a prospective investigation of neuroendocrine and psychobiological changes in weekend Ecstasy users. Neuropsychobiology (in press).
51. Logan, B. K., Couper, F. J. (2001). 3, 4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. Journal of Forensic Science, 46: 1426-1433.
52. Brookhuis, K. A., de Waard, D., Samyn, N. (2004). Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology, 173: 440-445.
53. Parrott, A. C., Milani, R.M., Gouzoulis-Mayfrank, R.M., Daumann, J. (2007). Cannabis and Ecstasy/MDMA (3, 4-methylenedioxymethamphetamine): an analysis of their neuropsychological interactions in recreational users. Journal of Neural Transmission, 114: 959-968.